A Study of Capecitabine (Xeloda) and Bevacizumab as a First-line Therapy in Patients With Metastatic Colorectal Cancer

Clinical trial NCT00069095 · COMPLETED

Trial details

NCT number: NCT00069095
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Colorectal Cancer

Start date: 2003-07-01
Primary completion: 2006-01-01
Enrollment: 2035

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.